Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRINeoS: Sugammadex vs Neostigmine for Lung Ventilation in Rats
NCT02284412Phase 4Completed
- Sponsor
- OLV Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2014
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by OLV Hospital. Started Dec 2014; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02284412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284412.